Staying consistent with your dosing schedule helps maintain steady results and prevents disruptions in appetite control and metabolic support benefits over time consistently
About half (54%) of those who report ever taking the drugs say it was difficult to afford them, including one in five (22%) who say it was very difficult. Having insurance coverage makes little difference to patients perceptions of the drugs affordability, with similar shares of those covered by insurance saying the drugs were difficult (53%) or very difficult (23%) to afford
After scrapping a Biden-era plan to cover obesity drugs in early 2025, the Trump administration reversed course: it struck deals with Novo Nordisk and Eli Lilly in November 2025 to cut GLP-1 prices, and a voluntary Medicare demonstration begins July 1, 2026 that lets participating drug plans cover GLP-1s for weight loss with a $50 monthly copay
doi: 10.1016/j.ahj.2013.03.020
[DOI] [PubMed] [Google Scholar] 85.Cossart P., Helenius A
In addition to a health plan many employers sponsor Employee Assistance Programs (EAP)
